News

  • Primary care is key to optimising value in healthcare 14 November 2017 Balancing improvements in health against the cost of such improvements in primary care is vital to achieve a cost-effective and efficient healthcare system, finds a new report by University of Bristol researchers and published in the BMJ.
  • New international consortium to accelerate drug discovery in kidney diseases 8 November 2017 A new consortium to accelerate the discovery of novel drugs to treat kidney diseases was announced on Monday, 6 November 2017. The NEPLEX (nephron on a chip with cellular and extracellular matrix complexity) consortium, comprising leading academic institutions including the Universities of Bristol and Cambridge, and Evotec AG, will combine key technologies to develop and build a novel drug discovery device ("Nephron-on-a-Chip").
  • New Health Integration Team focusing on stroke gets go-ahead 2 November 2017 A new Health Integration Team (HIT) focused on stroke has been given the go-ahead by the Bristol Health Partners executive group.
  • Novel pacemaker technology could transform treatment of heart failure 2 November 2017 Implantable devices to restore heart rhythm (eg pacemakers) are commonly used to treat heart failure and cardiovascular diseases. Groundbreaking technology, developed by academics at Bristol and Bath and supported by the EBI, promises to revolutionise the therapeutic potential of these implants.
  • A new method for the 3D printing of living artificial tissues 1 November 2017 A team from the University of Bristol’s School of Cellular and Molecular Medicine, together with scientists at the University of Oxford, has developed a new method to 3D-print stem cells to form complex living 3D structures.
  • Risk factors for heart health linked to marital ups and downs 24 October 2017 Risk factors for heart health seem to be linked to changes over time in the quality of marital relationships — at least for men — finds a University of Bristol study published in the Journal of Epidemiology & Community Health.
  • Cost-effectiveness of screening for atrial fibrillation 18 October 2017 Atrial fibrillation (AF) is a major cause of stroke and mortality. Many AF patients benefit from anticoagulation therapies, which have been shown to reduce the risk of an AF-related stroke. Earlier detection could prevent AF-related strokes, disability and mortality.
  • Erasmus Students 26 September 2017 Münevver Kökçü and Ayşenur Çetinkaya from Usak University in Turkey have been awarded an Erasmus student mobility programme scholarship to spend 3 months in Professor Suleiman’s Laboratory during the period July-October 2017.
  • BHF Clinical Fellowship awarded 26 September 2017 One of our academic clinical fellows in anaesthesia, Dr Katrina Hope, has been awarded a BHF Clinical Fellowship for 3 years.
  • Daniel Turnberg Travel Fellowship awarded 26 September 2017 Dr Safa Abdul-Ghani, a former PhD Student at the University of Bristol is currently an Assistant Professor in Physiology at Al-Quds University in Jerusalem, has been awarded a Daniel Turnberg Travel Fellowship to visit Professor Suleiman’s group this summer.

Bristol Heart Institute press releases

Press releases relating to cardiovascular research on University's central news pages.

Years iterator 2012201320142015201620172018
View all news
Edit this page